Three new long-acting injectable HIV medications suggest that 2-jabs-per-year HIV treatment is coming.
www.aidsmap.com
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could be components of future long-acting HIV treatment regimens, according to s...